Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
Anne H. Cross(Washington University in St. Louis), Robert W. Karr(Washington University in St. Louis)
Cited by 156
Related Papers
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
The contemporary spectrum of multiple sclerosis misdiagnosis
|Neurology|2016|324
Cell-based therapeutic strategies for multiple sclerosis
|Brain|2017|169
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
|Multiple Sclerosis Journal|2022|103